The Role of Non-Coding RNAs in Kidney Diseases

Laurent Metzinger; Juan Antonio Moreno; Valérie Metzinger-Le Meuth

doi:10.3390/ijms23126624

The Role of Non-Coding RNAs in Kidney Diseases

Int J Mol Sci. 2022 Jun 14;23(12):6624. doi: 10.3390/ijms23126624.

Authors

Laurent Metzinger¹, Juan Antonio Moreno^{2

3

4}, Valérie Metzinger-Le Meuth^{1

5}

Affiliations

¹ HEMATIM UR 4666, C.U.R.S, Université de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France.
² Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.
³ Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain.
⁴ Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14071 Cordoba, Spain.
⁵ INSERM UMRS 1148: Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Université Sorbonne Paris Nord, CEDEX, 93017 Bobigny, France.

Abstract

Renal diseases include different pathologies, such as acute kidney injury (AKI), chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetic nephropathy (DN), kidney cancer, polycystic kidney disease, etc [...].

Publication types

Editorial

MeSH terms

Acute Kidney Injury* / pathology
Diabetic Nephropathies* / genetics
Disease Progression
Humans
Kidney Failure, Chronic* / pathology
Renal Insufficiency, Chronic* / pathology
Risk Factors

Grants and funding

This research study was funded by SFNDT and Vifor (L.M. and V.M.-L.M.). This research was funded by Instituto de Salud Carlos III (ISCIII, FIS-FEDER PI17/00130, PI20/00375) (Co-funded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”)), Consejería de Salud y Familias-FEDER, Junta de Andalucía (PIGE-0052-2020), and Spanish Society of Nephrology (SEN). The Spanish Ministry of Science and Innovation supported the salary of J.A.M. (RYC-2017-22369) (Co-funded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”)) (J.A.M.).